United States v. Marcus’s Empirical Analysis
82 F.3d 606 · 1996
Citation profile
17 federal appellate ·
How this case has been cited
Cited by 23 later decisions — most recently July 2020
17 federal appellate ·
Later decisions citing this case, by decade. The current decade is in progress, and our corpus holds fewer opinions from the most recent years, so the latest bars are undercounted — not a real decline.
Relationships
Applies 18 U.S.C. § 371
Relies on United States v. Castner · United States v. Chatterji
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 23 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
“this is not a situation in which a drug with fraudulently obtained FDA approval harms consumers, fails to produce its intended effects, or is something less than its is represented to be.”
2 later decisions quote this exact passage · from the majority“consumers did not receive that for which they bargained--an FDA-approved drug of known safety and efficiency.”
2 later decisions quote this exact passage · from the majority“Given - 67 - the unchallenged finding that consumers would not purchase a drug of unknown safety and efficacy at any price, the district court correctly concluded that [the company's] gross sales were the appropriate measure of the actual loss suffered by consumers . . . .”
1 later decision quote this exact passage · from the majority
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.